Salus Alpha Special Situation Fund delivers strong returns
Salus Alpha RN Special Situation fund had delivered a good start to 2014 in terms of performance, according to the EXANE Report titled “Absolute Return UCITS Fund Performances – February 2014”, produced by Exane Derivatives Europe’s leading convertible research provider.
The Salus Alpha RN Special Situations fund delivered positive returns during the month of January, (Ranked 2nd out of 19 listed in the Exane Report under Event Driven UCITS) it was up by +1.90% and outperformed major peers by a positive margin of 1.35% on average during the month. The fund also enjoyed positive performance in 2013 contrary to most UCITS. Our fund was able to successfully withstand the major corrections in the equity markets taking advantage of volatility resulted from weak fundamentals across the globe. Market sentiment weakened further towards the end of the month, as the Federal Reserve announced another round of tapering which raised concerns regarding the health of the global recovery.
Mr. Prock, CEO and CIO of Salus Alpha Capital said:
“Our fund seem to repeat the January stint in February and in the coming months because our approach is unique and able to generate positive returns in all environments, since it combines an opportunistic core portfolio of selected, fundamentally attractively valued top companies with positions in short / medium - termed special situations and also the fund targets to achieve an absolute return independent of the development of the overall equity market. Therefore we are not dependant on trend as a sole source of alpha”.
About Salus Alpha
Salus Alpha Capital is a sophisticated Investment Manager and has established itself as a top expert in Alpha and Smart Beta Asset Management over the past decade. Our extensive Know-How in the space is characteristic of our company and our employees. The client base of Salus Alpha consists of institutional clients in Europe, Asia and in the USA. Salus Alpha operates from a network of global offices including Switzerland, Liechtenstein, Austria, the Netherlands, Singapore, India, and Hong Kong. We offer tailored solutions for clients and their financial needs, such as white label funds, managed accounts and structured products. For more information on Salus Alpha Capital, please visit http://sac.salusalpha.com/
For inquiries please contact
Andrea Moritz
+43 1 9572587 43
Appendix –
Rank
|
Event Driven UCITS
|
YTD Performance
|
1
|
MLIS - York Event Driven Ucits Fund
|
4.00%
|
2
|
Salus Alpha RN Special Situations
|
1.90%
|
3
|
MS PSAM Global Event UCITS Fund
|
1.80%
|
4
|
Dexia Risk Arbitrage
|
1.10%
|
5
|
Syquant Helium Performance
|
1.10%
|
6
|
Syquant Helium Opportunites
|
0.70%
|
7
|
CS Tremont Hedge Fund Risk Arbitrage
|
0.50%
|
8
|
Laffitte Risk Arbitrage
|
0.50%
|
9
|
Cigogne UCITS M&A Arbitrage
|
0.40%
|
10
|
Dexia Money + Risk Arbitrage
|
0.40%
|
11
|
ADI Risk Arbitrage Absolute Return
|
0.30%
|
12
|
CS Tremont Hedge Fund Event Driven
|
0.30%
|
13
|
Lutetia Patrimoine fund
|
0.30%
|
14
|
ADI Risk Arbitrages
|
0.10%
|
15
|
JP Morgan Global Merger Arbitrage Fund
|
0.10%
|
16
|
Pinebridge Merger Arbitrage Fund
|
0.00%
|
17
|
Westchester Merger Arbitrage
|
-0.30%
|
18
|
The Castlerigg Merger Arbitrage UCITS Fund
|
-0.50%
|
19
|
York Lion Merger Arbitrage Liquidity Fund UI
|
-0.90%
|
Table 1 – Performance comparison (Exane Derivatives - Absolute Return UCITS Fund Performances – February 2014)
